Most cited papers from Hospital Son Llatzer

Hospital Son Llatzer

What are the most cited papers from Hospital Son Llatzer?

The most cited paper from Hospital Son Llatzer is "Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial" (Rafael Rosell et al., 2012), with 5,563 citations. Next come "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis" (3,046) and "Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer" (2,388).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 142 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Rafael Rosell et al. · The Lancet Oncology Open access	30 Jan 2012	5,563
2	Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis David H Adams et al. · New England Journal of Medicine Open access	4 Jul 2018	3,046
3	Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer Rafael Rosell et al. · New England Journal of Medicine Open access	19 Aug 2009	2,388
4	Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Carl Zielinski et al. · The Lancet Open access	19 Sep 2009	1,122
5	Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension Miguel Ángel Martínez‐García et al. · JAMA Open access	11 Dec 2013	668
6	Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients Gonzalo Hernández, Concepción Vaquero, Paloma González Arenas et al. · JAMA Open access	15 Mar 2016	564
7	Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial María Goya, Laia Pratcorona, Carme Merced et al. · The Lancet	3 Apr 2012	465
8	Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial María‐Victoria Mateos et al. · The Lancet Oncology Open access	24 Aug 2010	463
9	Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain Jordi Rello et al. · Critical Care Open access	11 Sep 2009	451
10	Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza Jesús F. Bermejo-Martín et al. · Critical Care Open access	11 Dec 2009	383
11	Microplastic ingestion by Mullus surmuletus Linnaeus, 1758 fish and its potential for causing oxidative stress Carme Alomar, A. Sureda, Xavier Capó et al. · Environmental Research	8 Aug 2017	379
12	Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response Santos E. Perez-Pozo, Jesse D. Schold, Takahiko Nakagawa et al. · International Journal of Obesity	22 Dec 2009	347
13	Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study Ole Bernt Suhr, Teresa Coelho, Juan Buades et al. · Orphanet Journal of Rare Diseases Open access	2 Sep 2015	327
14	Validity, reproducibility, and responsiveness of a twelve‐joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis Esperanza Naredo et al. · Arthritis Care & Research	27 Mar 2008	293
15	Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy Marta Pratcorona, Salut Brunet, Josep F. Nomdedeu et al. · Blood	Feb 2013	286
16	Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma Bruno Paiva et al. · Journal of Clinical Oncology Open access	26 Nov 2019	282
17	Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy* José Garnacho‐Montero, Marcio Sa-Borges, Jordi Solé‐Violán et al. · Critical Care Medicine	20 Jun 2007	281
18	Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort Borja G. Cosío et al. · CHEST Journal	20 Aug 2015	278
19	Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Antonio Juan Más, Loreto Carmona, Marta Valverde et al. · PubMed	5 Feb 2009	262
20	Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality Ignasi Anguera et al. · European Heart Journal	30 Nov 2004	251
21	Update of the treatment of nosocomial pneumonia in the ICU Rafael Zaragoza, Pablo Vidal, Gerardo Aguilar et al. · Critical Care Open access	29 Jun 2020	250
22	Awareness with recall during general anaesthesia: a prospective observational evaluation of 4001 patients Carlos Luis Errando, Jeffrey C. Sigl, Matías Robles et al. · British Journal of Anaesthesia Open access	31 May 2008	246
23	Low Serum Mannose‐Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection Damon P. Eisen, Melinda Margaret Dean, Marja A. Boermeester et al. · Clinical Infectious Diseases Open access	8 Jul 2008	245
24	Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases Ana Crespo Catalá et al. · British Journal of Dermatology Open access	13 Jul 2021	244
25	Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial Niki Karachaliou et al. · JAMA Oncology Open access	26 Feb 2015	239
26	Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study Pedro Ruiz et al. · Movement Disorders	28 Apr 2008	234
27	Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma Laura Rosiñol et al. · Blood Open access	4 Sep 2019	220
28	Cervical pessary to prevent preterm birth in women with twin gestation and sonographic short cervix: a multicenter randomized controlled trial (PECEP-Twins) María Goya et al. · American Journal of Obstetrics and Gynecology Open access	25 Nov 2015	219
29	First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study Eduardo Díaz‐Rubio et al. · The Oncologist Open access	2012	213
30	A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy Emmanuel Bachy et al. · Blood Open access	17 Apr 2018	211
31	Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study Raquel Carbonell et al. · The Lancet Regional Health - Europe Open access	4 Nov 2021	207
32	What Is New in Listeriosis? Almudena Hernández-Milián, Antoni Payeras · BioMed Research International Open access	2014	197
33	Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer Julieta Grasselli et al. · Annals of Oncology Open access	13 Mar 2017	195
34	Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial María‐Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo et al. · The Lancet Oncology	9 Jul 2016	194
35	Dermoscopy of Dermatofibromas Pedro Diego Zaballos, Susana Puig, Álex Llambrich et al. · Archives of Dermatology	2008	188
36	Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Ciro Casanova et al. · European Respiratory Journal Open access	Nov 2017	187
37	Potential Anti-inflammatory Effects of Hesperidin from the Genus Citrus Silvia Tejada, Samuel Pinya, Miquel Martorell et al. · Current Medicinal Chemistry	19 Jul 2017	186
38	Host adaptive immunity deficiency in severe pandemic influenza Jesús F. Bermejo-Martín et al. · Critical Care Open access	14 Sep 2010	185
39	Determinants of Severity in Acute Pancreatitis Hanna Sternby et al. · Annals of Surgery	18 Apr 2018	180
40	Resveratrol and Alzheimer’s Disease: Mechanistic Insights Touqeer Ahmed, Sehrish Javed, Sana Javed et al. · Molecular Neurobiology	19 Mar 2016	180
41	Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis Benoit P. Guery, Maiken Cavling Arendrup, Georg M. Auzinger et al. · Intensive Care Medicine Open access	29 Oct 2008	174
42	Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study Antonio Albaya Moreno et al. · Intensive Care Medicine Open access471 authors	3 Aug 2018	170
43	Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer Luis G Paz-Ares, Helen J. Ross, Mary E.R. O'Brien et al. · British Journal of Cancer Open access	May 2008	169
44	Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology Jean Bousquet et al. · Journal of Allergy and Clinical Immunology Open access542 authors	28 Sep 2018	168
45	Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study* José Garnacho, Jordi Solé‐Violán, Marcio Sa-Borges et al. · Critical Care Medicine	Oct 2003	163
46	Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus Íñigo Rúa‐Figueroa et al. · Seminars in Arthritis and Rheumatism Open access	27 Jan 2017	162
47	Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma Cristina Pérez et al. · Blood Open access	23 Apr 2020	161
48	Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] G Perea et al. · Leukemia	10 Nov 2005	161
49	Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations Fernándo Domínguez et al. · Journal of the American College of Cardiology Open access	Nov 2018	160
50	Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study Miguel Nogué, Antonieta Salud, Pilar Vicente et al. · The Oncologist Open access	5 Apr 2011	158

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.